Synthetic MR AB (XSAT:SYNT) FCF Margin % : -17.25% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Synthetic MR AB's Free Cash Flow for the three months ended in Dec. 2023 was kr-5.20 Mil. Synthetic MR AB's Revenue for the three months ended in Dec. 2023 was kr30.12 Mil. Therefore, Synthetic MR AB's FCF Margin % for the quarter that ended in Dec. 2023 was -17.25%.

As of today, Synthetic MR AB's current FCF Yield % is -1.37%.

The historical rank and industry rank for Synthetic MR AB's FCF Margin % or its related term are showing as below:

XSAT:SYNT' s FCF Margin % Range Over the Past 10 Years
Min: -317.53 Med: -10.1 Max: 31.26
Current: -18.75

During the past 12 years, the highest FCF Margin % of Synthetic MR AB was 31.26%. The lowest was -317.53%. And the median was -10.10%.

XSAT:SYNT's FCF Margin % is ranked worse than
80.12% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 1.44 vs XSAT:SYNT: -18.75

Synthetic MR AB FCF Margin % Historical Data

The historical data trend for Synthetic MR AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB FCF Margin % Chart

Synthetic MR AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

19.96

-29.73

-1.49

-37.70

-18.70

Synthetic MR AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-36.30	-28.97	-33.68	1.37	-17.25

Competitive Comparison of Synthetic MR AB's FCF Margin %

For the Health Information Services subindustry, Synthetic MR AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synthetic MR AB's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's FCF Margin % falls into.

Synthetic MR AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Synthetic MR AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-16.679	/	89.213
	=	-18.70 %

Synthetic MR AB's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-5.195	/	30.119
	=	-17.25 %

Synthetic MR AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Synthetic MR AB (XSAT:SYNT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Storgatan 11, Linkoping, SWE, SE-582 23

Website

https://www.syntheticmr.com

Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.